Avid Bioservices, a dedicated biologics Contract Development and Manufacturing Organisation, has completed its acquisition by GHO Capital Partners LLP and Ampersand Capital Partners. This acquisition is poised to support Avid's next stage of rapid growth, including expanded offerings, talent investment, and greater geographic reach, leveraging the deep experience and expertise of GHO and Ampersand in the CDMO sector.